Ava

What Ava does

Ava is a Swiss-headquartered digital health company founded in 2014 that develops and sells a wearable fertility tracking bracelet and supporting mobile application for women's reproductive health. The core product is the Ava Fertility Tracker, a sensor bracelet worn during sleep that captures five physiological signals—skin temperature, resting pulse rate, breathing rate, heart rate variability ratio, and perfusion—and applies proprietary machine learning algorithms trained on more than 3.5 million menstrual cycles to identify the five most fertile days of each cycle in real time with approximately 90% accuracy. The device holds FDA 510(k) clearance and CE mark under EU MDR, making it the first and only FDA-cleared fertility tracking wearable, with clinical validation conducted in partnership with University Hospital Zurich, Columbia University, and Northwestern University.

The company operates a hybrid go-to-market model combining direct-to-consumer e-commerce through avawomen.com with B2B enterprise distribution through employer fertility benefit partnerships with Carrot Fertility (announced June 2020) and WINFertility (announced January 2022), as well as reseller channels including Aristo Pharma in Germany. Hardware is sold at $239 (Basic) and $309 (Plus) tiers, with the app bundled as a subscription, and the product is FSA/HSA eligible in the U.S. The product surface has expanded beyond fertility tracking to include pregnancy tracking (June 2021) and a standalone cycle tracking mode (2026), and the company has extended its sensor platform into COVID-19 pre-symptomatic detection through the COVID-RED consortium with Roche Diagnostics and University College London. Ava has offices in Zurich, Austin, San Francisco, Belgrade, and Makati, and reports over 50,000 pregnancies achieved by users as of December 2020 across 36 countries.

Name

Ava

Legal name

Awesome Health Inc

Website

https://avawomen.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

Ava is a Swiss digital health company that sells an FDA-cleared wearable bracelet using machine learning on multi-sensor physiological data to identify fertile days for women trying to conceive, sold direct-to-consumer and through employer fertility benefit partnerships.

Ownership category

akta.pro rank

Product category

Women's Reproductive Health Wearables

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices) (CRACAQAJ)

akta.pro secondary industries

Maternal & High-Risk Pregnancy Remote Monitoring (BP, glucose, fetal/uterine monitoring) (HLALAFAG), Sleep Tracking Devices (Wearables & Non-wearables) (CRACAQAD)

Keywords

• Fertility tracking wearable
• Cycle monitoring device
• Reproductive health technology
• AI-powered fertility
• Women's health wearable

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Hardware Sales: Sale of Ava fertility tracking bracelet hardware. Ava Fertility Basic priced at $239, Ava Fertility Plus at $309. One-time purchase with optional accessory straps.
2. Subscription Software Access: The Ava app provides cycle tracking, fertility insights, and pregnancy monitoring. The company also offers access to Awesome Woman app for reproductive health content.
3. B2B Enterprise Sales: Partnership with Carrot Fertility and WINFertility to offer Ava bracelet as employer fertility benefit. Companies reimburse employees for the device.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Ava sells an FDA-cleared, patented multi-sensor bracelet worn during sleep that tracks five physiological parameters (skin temperature, resting pulse rate, breathing rate, heart rate variability ratio, and perfusion) and uses machine learning algorithms to identify a woman's five most fertile days per menstrual cycle in real time with approximately 90% accuracy. The bracelet pairs with a companion app that supports fertility tracking, cycle tracking, and pregnancy tracking modes. The product is sold direct-to-consumer and through employer fertility benefit partnerships.

Product overview

Ava is a digital health company offering a suite of connected wearable and software products for women's reproductive health. The core product is the FDA-cleared Ava Fertility Tracker bracelet, which uses multi-parameter physiological sensing and machine learning to detect fertile days. The product ecosystem spans three modes: Fertility Tracking (the primary product for conception support), Cycle Tracking (standalone cycle monitoring), and Pregnancy Tracking (post-conception support). Ava 2.0 represents the current-generation hardware with updated sensors and straps. The company sells direct-to-consumer with employer benefit partnerships through platforms like Carrot Fertility and WINFertility.

Differentiator

Problem solved

Functional benefit

Products and services

• Ava Fertility Tracker FDA-cleared fertility tracking sensor bracelet worn during sleep that monitors five physiological parameters (skin temperature, resting pulse rate, breathing rate, heart rate variability, and perfusion) and uses machine learning algorithms to detect a woman's five most fertile days of the menstrual cycle in real-time with approximately 90% accuracy. The first and only FDA-cleared fertility tracking wearable.
• Ava Cycle Tracking Standalone cycle tracking offering within the Ava ecosystem for women not actively trying to conceive. Tracks physiological parameters correlated with reproductive hormone fluctuations for higher precision cycle monitoring compared to traditional methods.
• Ava Pregnancy Tracking Post-conception pregnancy tracking feature providing graphs, trend analysis, and week-by-week content throughout the nine-month pregnancy. Uses continuous physiological monitoring from the Ava bracelet to follow pregnancy progress.
• Ava Straps & Accessories Replacement straps and accessories for the Ava bracelet, including the updated Ava 2.0 sensor pod with sleeker strap design.

Quantifiable outcome

• Women using Ava Fertility before trying to conceive get pregnant faster
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Ten partnerships are on record, tiered core, strategic and minor.

• WINFertilitycoreChannel Partner/ Reseller/ Distributor · 18 January 2022Partnership with WINFertility, the nation's leading family-building and fertility benefit management company with the largest portfolio of employer clients. WINFertility makes Ava bracelet available to its members as an alternate pathway to data-driven technology that increases natural conception chances.
• COVID-RED ConsortiumstrategicStrategic or Co-development Partner · 23 March 2021COVID-RED clinical trial in partnership with global experts in public health, epidemiology, biomedical informatics, wearable sensor technology, and machine learning. Consortium includes Ava, Julius Clinical Research, Labormedizinisches Zentrum Dr Risch, Roche Diagnostics Nederland, Sanquin, Takeda Pharmaceuticals, University College London, UMC Utrecht, and Vive. Over 20,000 participants testing Ava's COVID-19 detection algorithm.
• Roche DiagnosticscoreStrategic or Co-development Partner · 23 March 2021Partner in COVID-RED consortium providing diagnostic testing capabilities. Ava provides infection detection algorithm; Roche provides access to diagnostic tests for participants identified as potentially ill by the app.
• SanquinminorStrategic or Co-development Partner · 23 March 2021Partner in COVID-RED consortium. Stichting Sanquin Bloedvoorziening participates in the clinical trial for COVID-19 early detection using Ava's sensor bracelet.
• Columbia UniversitycoreStrategic or Co-development Partner · 8 February 2021Academic partner for clinical studies on Ava fertility tracking bracelet in collaboration with academic partners around the world.
• Northwestern University Feinberg School of MedicinecoreStrategic or Co-development Partner · 8 February 2021Academic partner for clinical studies on Ava fertility tracking bracelet. Northwestern University participates in ongoing clinical validation research.
• Aristo PharmaminorChannel Partner/ Reseller/ Distributor · 1 October 2020Partnership with Aristo Pharma in Germany for distribution and commercial presence in the German market.
• Carrot FertilitycoreChannel Partner/ Reseller/ Distributor · 7 June 2020Partnership with Carrot Fertility, the leading global fertility benefits provider for employers. The Ava bracelet is now provided as a fertility benefit through Carrot, available to Carrot members at significant discount. Combined with Carrot's telehealth services, this offers comprehensive in-home fertility support through the 'Carrot at Home' program.
• University Hospital ZurichcoreStrategic or Co-development Partner · 1 May 2020Clinical research partner conducting studies on Ava's fertility tracking technology. University Hospital of Zurich conducted clinical studies on resting pulse rate and other physiological parameters throughout menstrual cycles.
• Dr Risch Group (COVI-GAPP Study)strategicStrategic or Co-development Partner · 14 April 2020Consortium led by Professor Dr. Lorenz Risch and Dr. Martin Risch of the Dr Risch Group in Liechtenstein launched the COVI-GAPP study. Around 2,000 individuals using Ava bracelets to investigate whether the sensor can detect COVID-19 infection early. Study uses existing GAPP research infrastructure with permits from Zurich's Cantonal Ethics Committee.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Flo Health: Flo is the world's most popular women's health app with 70M+ monthly active users, offering cycle tracking, ovulation prediction, and pregnancy mode. Comparable to Ava in addressing fertility tracking for women trying to conceive, but through a smartphone-based app rather than wearable hardware.
• Natural Cycles: Natural Cycles is the first FDA-cleared digital contraceptive and offers a fertility tracking app using basal body temperature and algorithm-based ovulation prediction. It is the most direct competitor to Ava as both target women trying to conceive or avoid pregnancy with FDA-cleared digital solutions.
• Oura: Oura makes a smart ring that tracks physiological signals (skin temperature, HRV, resting heart rate, breathing rate) worn during sleep. Ava and Oura share a similar wearable form factor and multi-parameter physiological sensing approach, with Oura adding cycle/fertility insights to its app.
• Clue: Clue is a leading menstrual cycle tracking app with ~10M+ users, focused on reproductive health and fertility awareness. Comparable to Ava as a fertility/cycle tracking solution targeting similar consumer segments, though delivered via smartphone app rather than wearable hardware.
• Tempdrop: Tempdrop is a wearable fertility tracker worn during sleep that measures basal body temperature to predict ovulation. It competes directly with Ava in the home fertility tracking category for women trying to conceive, using a similar wear-only-at-night approach.

Broad incumbents

• Fitbit (Google): Fitbit offers health wearables with sleep tracking, heart rate variability, and women's health features including menstrual cycle tracking. Similar broad incumbent status to Apple Watch as a multi-purpose wearable that competes with Ava's health-tracking proposition.
• Clearblue: Clearblue is the established global leader in home ovulation and pregnancy tests, including connected/smart fertility monitors. Ava competes with Clearblue's LH-based ovulation tests which Ava claims to outperform by detecting twice as many fertile days.
• Apple (Apple Watch): Apple Watch includes wrist temperature sensing, HRV, and cycle tracking features built into iOS. Apple is a broad incumbent with overlapping physiological sensing capabilities that could erode Ava's dedicated device value proposition if cycle tracking accuracy improves.

Emerging players

• Mira: Mira is an emerging at-home hormone monitoring system that quantifies hormone concentrations (LH, E3G, PdG) via disposable test wands and a connected analyzer. It overlaps with Ava in fertility tracking but focuses on quantitative hormone measurement rather than continuous physiological sensing.
• Eli Health: Eli Health is an emerging femtech company developing continuous hormone monitoring via saliva-based wearable sensors. It represents the next generation of women's reproductive health monitoring that could compete with Ava's physiological sensing approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/avawomen
• YouTubeyoutube.com/channel/UCZ1BceGFRgHo0kIZGaRWHsQ
• Facebookfacebook.com/avabracelet
• LinkedInlinkedin.com/company/ava-ag
• Instagraminstagram.com/avawomen

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds7 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ava